Shoshin beriberi-thiamine responsive pulmonary hypertension in exclusively breastfed infants: A study from northern

Javeed Iqbal Bhat1, Hilal Ahmad Rather2, Ambreen Ali Ahangar3

  • 1Department of Pediatrics, SKIMS Srinagar, J&K, India.

Indian Heart Journal
|February 24, 2017
PubMed

Insights

Thiamine administration effectively resolved pulmonary hypertension in exclusively breastfed infants with Shoshin beriberi. This intervention rapidly reversed high pulmonary pressures and metabolic complications, offering a promising treatment.

Area of Science:

  • Pediatrics
  • Cardiology
  • Nutritional Science

Background:

  • Shoshin beriberi, a severe form of thiamine deficiency, can present with critical cardiovascular complications.
  • Pulmonary hypertension is a significant and potentially fatal complication in infants with Shoshin beriberi.

Purpose of the Study:

  • To investigate the efficacy of thiamine administration in resolving pulmonary hypertension in exclusively breastfed infants diagnosed with Shoshin beriberi.

Main Methods:

  • A prospective cohort study was conducted in a tertiary care hospital.
  • Twenty-nine exclusively breastfed infants with Shoshin beriberi and pulmonary hypertension received intravenous thiamine (100mg/kg stat, then 10mg/day).
  • Outcomes assessed included resolution of shock, metabolic complications, and pulmonary hypertension via echocardiography.

Main Results:

  • All infants presented with pulmonary hypertension and acute metabolic acidosis.
  • Following thiamine administration, repeat echocardiography demonstrated complete resolution of pulmonary hypertension.
  • Four deaths occurred, but the primary cardiovascular complication showed prompt reversal.

Conclusions:

  • Infants with Shoshin beriberi can exhibit severe pulmonary hypertension that is responsive to thiamine.
  • Thiamine challenge provides rapid resolution of metabolic derangements and reverses pulmonary hypertension.
  • This study highlights the critical role of thiamine in managing Shoshin beriberi-associated cardiovascular compromise.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
718
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
738